Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Tumor-secreted FGF21 acts as an immune suppressor by rewiring cholesterol metabolism of CD8+T cells
Cegui Hu, Wen Qiao, Xiang Li, et al.
Cell Metabolism (2024) Vol. 36, Iss. 3, pp. 630-647.e8
Closed Access | Times Cited: 22

Showing 22 citing articles:

Breast cancer: pathogenesis and treatments
Xin Xiong, Lewei Zheng, Yu‐Qiang Ding, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 5
Immunometabolism of CD8+ T cell differentiation in cancer
Hao Shi, Sidi Chen, Hongbo Chi
Trends in cancer (2024) Vol. 10, Iss. 7, pp. 610-626
Closed Access | Times Cited: 13
Metabolic dysfunction-associated steatotic liver disease and extrahepatic gastrointestinal cancers
Alessandro Mantovani, Amedeo Lonardo, Norbert Stefan, et al.
Metabolism (2024) Vol. 160, pp. 156014-156014
Closed Access | Times Cited: 10
A functional single-cell metabolic survey identifies Elovl1 as a target to enhance CD8+ T cell fitness in solid tumours
Samantha Pretto, Qian Yu, Pierre Bourdely, et al.
Nature Metabolism (2025)
Open Access | Times Cited: 1
Targeting the mevalonate pathway potentiates NUAK1 inhibition-induced immunogenic cell death and antitumor immunity
Liming Gui, Kaiwen W. Chen, Jingjing Yan, et al.
Cell Reports Medicine (2025), pp. 101913-101913
Open Access
Spatiotemporal metabolomic approaches to the cancer-immunity panorama: a methodological perspective
Yang Xiao, Yongsheng Li, Huakan Zhao
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 4
Macrophages and T cells in metabolic disorder-associated cancers
Daniel Taranto, Daan J. Kloosterman, Leila Akkari
Nature reviews. Cancer (2024)
Closed Access | Times Cited: 4
Tumor metabolic regulators: key drivers of metabolic reprogramming and the promising targets in cancer therapy
Kun Huang, Ying Han, Yihong Chen, et al.
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access
New insights into the role of complement system in colorectal cancer (Review)
Yu‐wen Xu, Jiaqi Zhou, Yuanyuan Wu, et al.
Molecular Medicine Reports (2025) Vol. 31, Iss. 3
Open Access
Disrupting cholesterol homeostasis in T cells boosts antitumour responses
Kelly T. Kennewick, Steven J. Bensinger
Nature Metabolism (2025)
Closed Access
Spatial genomics reveals cholesterol metabolism as a key factor in colorectal cancer immunotherapy resistance
Andrew J. Kavran, Yulong Bai, Brian Rabe, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
The Role of Cholesterol Metabolism and Its Regulation in Tumor Development
Yongmei Wu, Wenqian Song, Su Min, et al.
Cancer Medicine (2025) Vol. 14, Iss. 7
Open Access
Suppressor of cytokine signaling 2 modulates regulatory T cell activity to suppress liver hepatocellular carcinoma growth and metastasis
Xi Lan, Heng Zhang, Z. Chen, et al.
World Journal of Gastroenterology (2025) Vol. 31, Iss. 13
Closed Access
Lipid metabolism in tumor-infiltrating regulatory T cells: perspective to precision immunotherapy
Yukai Shan, Tian‐Ao Xie, Yuchao Sun, et al.
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 3
The roles of cancer stem cell-derived secretory factors in shaping the immunosuppressive tumor microenvironment in hepatocellular carcinoma
Gregory Kenneth Muliawan, Terence K. Lee
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Nanomaterial-enabled metabolic reprogramming strategies for boosting antitumor immunity
Mengdi Ma, Yongliang Zhang, Kanyi Pu, et al.
Chemical Society Reviews (2024)
Closed Access | Times Cited: 1
Targeting lipid metabolism via nanomedicine: a prospective strategy for cancer therapy
Xing Huang, Shengzhong Hou, Yinggang Li, et al.
Biomaterials (2024) Vol. 317, pp. 123022-123022
Closed Access | Times Cited: 1
tRNA m1A modification regulates cholesterol biosynthesis to promote antitumor immunity of CD8+ T cells
Shan Miao, Hao Li, Xiaohan Song, et al.
The Journal of Experimental Medicine (2024) Vol. 222, Iss. 3
Closed Access | Times Cited: 1
FGF21 suppresses CD8+ T cell antitumour activity
Olivia Tysoe
Nature Reviews Endocrinology (2024) Vol. 20, Iss. 4, pp. 191-191
Closed Access
FGF21 Counteracts Adipose Tissue Wasting in Cancer-Associated Cachexia
Tamina Österreicher, Kristina Kührer, Anna-Lena Höbler, et al.
(2024)
Closed Access
Insights into the role of FGF21 in coronary heart disease
Qin-Yao Zhang, Hui‐Xin Liu
International Journal of Biological Macromolecules (2024), pp. 136911-136911
Closed Access
Growth Hormone Action as a Target in Cancer: Significance, Mechanisms and Possible Therapies
Reetobrata Basu, César Luiz Boguszewski, John J. Kopchick
Endocrine Reviews (2024)
Open Access
Adipocyte FGF21 Signaling Defect Aggravated Adipose Tissue Inflammation in Gestational Diabetes Mellitus
Lun Hua, Yi Yang, Haoqi Zhang, et al.
Nutrients (2024) Vol. 16, Iss. 22, pp. 3826-3826
Open Access
Page 1

Scroll to top